Literature DB >> 23085967

Prognostic factors in patients undergoing complete resection of pulmonary metastases of colorectal cancer: a multi-institutional cumulative follow-up study.

Tomoichiro Hirosawa1, Michio Itabashi, Takamasa Ohnuki, Naohito Yamaguchi, Kenichi Sugihara, Shingo Kameoka.   

Abstract

PURPOSE: The aim of this retrospective study was to establish the prognostic factors for overall survival after pulmonary resection for lung metastases of colorectal carcinoma (CRC).
METHODS: The baseline characteristics and outcomes of 266 CRC patients undergoing complete pulmonary resection were collected from 19 institutions by the Japanese Society for Cancer of the Colon and Rectum (JSCCR) Study Group. We used the Cox proportional hazard regression to identify independent prognostic factors for OS.
RESULTS: The 5-year overall survival rate of patients undergoing complete resection of isolated pulmonary metastases was 56.5 %. The independent unfavorable prognostic factors after pulmonary resection included stage T4 (p = 0.0004) and N2 (p = 0.0082) as primary cancer-related factors, and more than three metastases (p = 0.0342), bilateral distribution (p = 0.0450), metastatic disease-free interval (DFI) of less than 2 years (p = 0.0257), and a preoperative carcinoembryonic antigen (CEA) level greater than 5.0 ng/mL (p = 0.0209) as pulmonary metastases-related factors.
CONCLUSIONS: This retrospective analysis suggested that the indications for pulmonary resection of CRC metastases should be decided not only by the status of lung metastases, but also by pulmonary-related factors such as the T and N stage of the primary lesion, preoperative CEA level, and the DFI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23085967     DOI: 10.1007/s00595-012-0373-8

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  24 in total

1.  THE SURGICAL TREATMENT OF METASTATIC TUMORS IN THE LUNGS.

Authors:  N R THOMFORD; L B WOOLNER; O T CLAGETT
Journal:  J Thorac Cardiovasc Surg       Date:  1965-03       Impact factor: 5.209

2.  Pulmonary metastasectomy for 165 patients with colorectal carcinoma: A prognostic assessment.

Authors:  Yukihito Saito; Hideyasu Omiya; Keijiro Kohno; Takanobu Kobayashi; Kazumi Itoi; Masami Teramachi; Masato Sasaki; Hitoyuki Suzuki; Hitoji Takao; Masaharu Nakade
Journal:  J Thorac Cardiovasc Surg       Date:  2002-11       Impact factor: 5.209

3.  Survival, disease-free interval, and associated tumor features in patients with colon/rectal carcinomas and their resected intra-pulmonary metastases.

Authors:  S Zink; G Kayser; H J Gabius; K Kayser
Journal:  Eur J Cardiothorac Surg       Date:  2001-06       Impact factor: 4.191

Review 4.  Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis.

Authors:  Francesca Fiorentino; Ian Hunt; Kristine Teoh; Tom Treasure; Martin Utley
Journal:  J R Soc Med       Date:  2010-02       Impact factor: 5.344

5.  Characteristic differences between patients who have undergone surgical treatment for lung metastasis or hepatic metastasis from colorectal cancer.

Authors:  A Iwasaki; T Shirakusa; Y Yamashita; T Noritomi; T Maekawa; T Hamada
Journal:  Thorac Cardiovasc Surg       Date:  2005-12       Impact factor: 1.827

6.  Prognostic factors of pulmonary metastasectomy for colorectal carcinomas.

Authors:  Fengshi Chen; Nobuharu Hanaoka; Kiyoshi Sato; Takuji Fujinaga; Makoto Sonobe; Tsuyoshi Shoji; Hiroaki Sakai; Ryo Miyahara; Toru Bando; Kenichi Okubo; Toshiki Hirata; Hiroshi Date
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

7.  Pulmonary resection for colorectal cancer metastases: duration between cancer onset and lung metastasis as an important prognostic factor.

Authors:  Been-Ren Lin; Tung-Chen Chang; Yung-Chie Lee; Po-Huang Lee; King-Jen Chang; Jin-Tung Liang
Journal:  Ann Surg Oncol       Date:  2009-01-29       Impact factor: 5.344

Review 8.  Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma.

Authors:  Masayoshi Inoue; Mitsunori Ohta; Keiji Iuchi; Akihide Matsumura; Kan Ideguchi; Tsutomu Yasumitsu; Katsuhiro Nakagawa; Kenjiro Fukuhara; Hajime Maeda; Shin-ichi Takeda; Masato Minami; Yuko Ohno; Hikaru Matsuda
Journal:  Ann Thorac Surg       Date:  2004-07       Impact factor: 4.330

9.  Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases.

Authors:  George Miller; Peter Biernacki; Nancy E Kemeny; Mithat Gonen; Robert Downey; William R Jarnagin; Michael D'Angelica; Yuman Fong; Leslie H Blumgart; Ronald P DeMatteo
Journal:  J Am Coll Surg       Date:  2007-06-27       Impact factor: 6.113

10.  Factors influencing survival after complete resection of pulmonary metastases from colorectal cancer.

Authors:  K Watanabe; K Nagai; A Kobayashi; M Sugito; N Saito
Journal:  Br J Surg       Date:  2009-09       Impact factor: 6.939

View more
  22 in total

1.  Impact of inappropriate lymphadenectomy on lung metastasectomy for patients with metastatic colorectal cancer.

Authors:  Sergi Call; Ramón Rami-Porta; Raúl Embún; Laura Casas; Juan J Rivas; Laureano Molins; José Belda-Sanchís
Journal:  Surg Today       Date:  2015-07-05       Impact factor: 2.549

2.  Surgical outcomes of pulmonary metastases from esophageal carcinoma diagnosed by both pathological and clinical criteria.

Authors:  Yoshiki Kozu; Shiaki Oh; Kazuya Takamochi; Kenji Suzuki
Journal:  Surg Today       Date:  2014-09-18       Impact factor: 2.549

3.  Outcomes of Hybrid Video Assisted Thoracoscopic Surgery for Pulmonary Metastasectomy.

Authors:  Ali Raza; Kazuaki Takabe; Luke G Wolfe; C Gregory Lockhart; Roger H Kim
Journal:  J Surg Sci       Date:  2014-12

4.  Surgical Management of Metastatic Colorectal Cancer: A Single-Centre Experience on Oncological Outcomes of Pulmonary Resection vs Cytoreductive Surgery and HIPEC.

Authors:  Evelyn Yi Ting Wong; Grace Hwei Ching Tan; Deanna Wan Jie Ng; Tina Puay Theng Koh; Mrinal Kumar; Melissa Ching Ching Teo
Journal:  J Gastrointest Cancer       Date:  2017-12

5.  Prognostic Significance of the Immunological Indices in Patients Who Underwent Complete Resection of Pulmonary Metastases of Colorectal Cancer.

Authors:  Yuki Okazaki; Masatsune Shibutani; E N Wang; Hisashi Nagahara; Tatsunari Fukuoka; Yasuhito Iseki; Shinichiro Kashiwagi; Hiroaki Tanaka; Kiyoshi Maeda; Kosei Hirakawa; Masaichi Ohira
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

6.  Radical lymphadenectomy of a para-aorta lymph node metastasis in colorectal cancer prolongs relapse-free survival.

Authors:  Yoshitoshi Ichikawa; Hidekazu Takahashi; Makoto Fujii; Tsuyoshi Hata; Takayuki Ogino; Norikatsu Miyoshi; Mamoru Uemura; Hirofumi Yamamoto; Tsunekazu Mizushima; Yuichiro Doki; Hidetoshi Eguchi
Journal:  Int J Colorectal Dis       Date:  2021-05-27       Impact factor: 2.571

7.  Minimally invasive surgery using the open magnetic resonance imaging system combined with video-assisted thoracoscopic surgery for synchronous hepatic and pulmonary metastases from colorectal cancer: report of four cases.

Authors:  Hiromichi Sonoda; Tomoharu Shimizu; Katsushi Takebayashi; Hiroyuki Ohta; Koichiro Murakami; Hisanori Shiomi; Shigeyuki Naka; Jun Hanaoka; Tohru Tani
Journal:  Surg Today       Date:  2014-08-07       Impact factor: 2.549

8.  Proposal of a new prognostic staging system for pulmonary metastases from colorectal cancer.

Authors:  Tomoichiro Hirosawa; Michio Itabashi; Takamasa Ohnuki; Naoto Yamaguchi; Kenichi Sugihara; Shingo Kameoka
Journal:  Surg Today       Date:  2014-07-25       Impact factor: 2.549

Review 9.  The management of the advanced colorectal cancer: management of the pulmonary metastases.

Authors:  Charalambos Zisis; Kosmas Tsakiridis; Ioanna Kougioumtzi; Paul Zarogoulidis; Kaid Darwiche; Nikolaos Machairiotis; Bojan Zaric; Nikolaos Katsikogiannis; Georgios Kesisis; Aikaterini Stylianaki; Zhigang Li; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2013-09       Impact factor: 2.895

10.  Patients with colorectal lung oligometastases (L-OMD) treated by dose adapted SABR at diagnosis of oligometastatic disease have better outcomes than patients previously treated for their metastatic disease.

Authors:  Alina Mihai; Yijia Mu; John Armstrong; Mary Dunne; Sushil Beriwal; Luke Rock; Pierre Thirion; Dwight E Heron; Brian Healy Bird; Jennifer Westrup; Conleth Gerard Murphy; M Saiful Huq; Raymond McDermott
Journal:  J Radiosurg SBRT       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.